Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nima Mousavi

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Gastrointestinal Cancer|April 15, 2022
Duloxetine for the Prevention of Oxaliplatin Induced Peripheral Neuropathy: A Randomized, Placebo-Controlled, Double-blind Clinical TrialMahdi Aghili, Nima Mousavi Darzikolaee, Mohammad Babaei, et al.
Journal of Medical Radiation Sciences|August 20, 2021
Low-dose whole-lung irradiation in severe COVID-19 pneumonia: a controlled clinical trialNima Mousavi Darzikolaee, Kasra Kolahdouzan, Hamidreza Abtahi, et al.
Clinical and Translational Radiation Oncology|April 20, 2026
Phase II randomized trial of 41.4 Gy vs. 50.4 Gy in neoadjuvant chemoradiotherapy for resectable esophageal cancerEbrahim Esmati, Reza Nazari, Ali Aqamolaei, et al.
Genome Research|May 1, 2023
A novel quantitative trait locus implicates <i>Msh3</i> in the propensity for genome-wide short tandem repeat expansions in miceMikhail O Maksimov, Cynthia Wu, David G Ashbrook, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|June 13, 2022
HMOX1 Genetic Polymorphisms Display Ancestral Diversity and May Be Linked to Hypertensive Disorders in PregnancyTianyanxin Sun, Giovanna I Cruz, Nima Mousavi, et al.
Radiation Oncology Journal|January 3, 2025
Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients: a real-world single institution experienceReza Ghalehtaki, Kasra Kolahdouzan, Guglielmo Niccolò Piozzi, et al.
Clinical and Translational Radiation Oncology|July 22, 2024
Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical diseaseLuca Nicosia, Andrea Gaetano Allegra, Niccolò Giaj-Levra, et al.
Nature Communications|October 23, 2023
A deep population reference panel of tandem repeat variationHelyaneh Ziaei Jam, Yang Li, Ross DeVito, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
A deep population reference panel of tandem repeat variationHelyaneh Ziaei Jam, Yang Li, Ross DeVito, et al.
Radiation Oncology (London, England)|December 3, 2024
Short-term and long-term oncological outcomes of chemoradiotherapy for rectal cancer patients with or without oxaliplatin: a propensity score-matched retrospective analysisAmirali Azimi, Fatemeh Sadat Tabatabaei, Kasra Kolahdouzan, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Gastrointestinal Cancer|April 15, 2022
Duloxetine for the Prevention of Oxaliplatin Induced Peripheral Neuropathy: A Randomized, Placebo-Controlled, Double-blind Clinical TrialMahdi Aghili, Nima Mousavi Darzikolaee, Mohammad Babaei, et al.
Journal of Medical Radiation Sciences|August 20, 2021
Low-dose whole-lung irradiation in severe COVID-19 pneumonia: a controlled clinical trialNima Mousavi Darzikolaee, Kasra Kolahdouzan, Hamidreza Abtahi, et al.
Clinical and Translational Radiation Oncology|April 20, 2026
Phase II randomized trial of 41.4 Gy vs. 50.4 Gy in neoadjuvant chemoradiotherapy for resectable esophageal cancerEbrahim Esmati, Reza Nazari, Ali Aqamolaei, et al.
Genome Research|May 1, 2023
A novel quantitative trait locus implicates <i>Msh3</i> in the propensity for genome-wide short tandem repeat expansions in miceMikhail O Maksimov, Cynthia Wu, David G Ashbrook, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|June 13, 2022
HMOX1 Genetic Polymorphisms Display Ancestral Diversity and May Be Linked to Hypertensive Disorders in PregnancyTianyanxin Sun, Giovanna I Cruz, Nima Mousavi, et al.
Radiation Oncology Journal|January 3, 2025
Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients: a real-world single institution experienceReza Ghalehtaki, Kasra Kolahdouzan, Guglielmo Niccolò Piozzi, et al.
Clinical and Translational Radiation Oncology|July 22, 2024
Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical diseaseLuca Nicosia, Andrea Gaetano Allegra, Niccolò Giaj-Levra, et al.
Nature Communications|October 23, 2023
A deep population reference panel of tandem repeat variationHelyaneh Ziaei Jam, Yang Li, Ross DeVito, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
A deep population reference panel of tandem repeat variationHelyaneh Ziaei Jam, Yang Li, Ross DeVito, et al.
Radiation Oncology (London, England)|December 3, 2024
Short-term and long-term oncological outcomes of chemoradiotherapy for rectal cancer patients with or without oxaliplatin: a propensity score-matched retrospective analysisAmirali Azimi, Fatemeh Sadat Tabatabaei, Kasra Kolahdouzan, et al.
Pageof 4